Skip to content

Neuronetics STIM Clinical Services — Gross Profit

Other segment segments

Medical Device
$10.07M-1.0%

Similar metrics at other companies

SRT
SRTAClinical — Gross Profit
$4.95M
Guidewire Software logo
GWREServices — Gross Profit
$4.17M+114%
Insight Enterprises logo
NSITServices — Gross Profit
$283.25M+22.9%
Consolidated Water Company logo
CWCOServices — Gross Profit
$2.82M+40.1%
Simulations Plus logo
SLPServices — Gross Profit
$3.16M+41.5%
American Tower logo
AMTServices — Gross Profit
$29.1M-26.7%

Other financials

Income statement

See full
Revenue$34.5M+7.8%
Gross profit$16.2M+2.6%
Operating income-$9.0M+18.3%
Net income-$10.8M+14.9%
EPS (diluted)-$0.16+23.8%

Balance sheet

See full
Cash & equivalents$13.2M-34.7%
Total debt$85.4M+3.5%
Total equity$13.3M-62.6%
Total assets$125.4M-11.7%

Cash flow

See full
Operating cash flow-$9.4M+44.6%
CapEx$197.0K-10.0%
Free cash flow-$9.6M+44.1%

Valuation

See full
Market cap$90.46M-59.6%
Enterprise value$162.64M-44.6%
P/S0.6×-1.4×

Profitability

See full
Gross margin48%-15.6pp
Operating margin-19.4%-6.9pp
Net margin-24.5%-8.7pp
FCF margin-9.4%-4.1pp

Returns & leverage

See full
Return on equity-152.4%-1.4pp
Debt / equity6.4×+4.1×
Current ratio1.7×-0.8×

Where this comes from

Reported directly by Neuronetics in its filing.

Tagged under the XBRL concept us-gaap:GrossProfit.

The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuronetics's clinical services — gross profit.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neuronetics's clinical services — gross profit?
Neuronetics (STIM) reported clinical services — gross profit of $6.09M in Q1 2026.
How has Neuronetics's clinical services — gross profit changed year-over-year?
Neuronetics's clinical services — gross profit increased by 9.2% year-over-year, from $5.57M to $6.09M.
What does clinical services — gross profit mean?
This metric is calculated as the revenue from clinical services minus the direct costs of providing those services. It reflects the fundamental profitability of the clinical services business model before accounting for broader operating expenses.